- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics stock price live, this page displays NASDAQ MLTX stock exchange data. View the MLTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the MoonLake Immunotherapeutics real time stock price chart below.
What Is the MoonLake Immunotherapeutics Stock Price Today?
The MoonLake Immunotherapeutics stock price today is 12.20.
What Is the Stock Symbol for MoonLake Immunotherapeutics?
The stock symbol for MoonLake Immunotherapeutics is "MLTX."
What Stock Exchange Does MoonLake Immunotherapeutics Trade On?
MoonLake Immunotherapeutics is listed and trades on the NASDAQ stock exchange.
Is MoonLake Immunotherapeutics a Good Stock to Buy?
Determining whether MoonLake Immunotherapeutics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MLTX quote. (ISIN: KY61559X1045)
What Is the MoonLake Immunotherapeutics Stock Price Today?
The MoonLake Immunotherapeutics stock price today is 12.20.
What Is the Stock Symbol for MoonLake Immunotherapeutics?
The stock symbol for MoonLake Immunotherapeutics is "MLTX."
What Stock Exchange Does MoonLake Immunotherapeutics Trade On?
MoonLake Immunotherapeutics is listed and trades on the NASDAQ stock exchange.
Is MoonLake Immunotherapeutics a Good Stock to Buy?
Determining whether MoonLake Immunotherapeutics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MLTX quote. (ISIN: KY61559X1045)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.02
12.70
52 wk Range
5.95
62.75
MLTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.0212.70
52 wk Range
5.9562.75
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MLTX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
28.54
Upside
+133.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
6 analysts have revised their earnings upwards for the upcoming period
Form 4 MoonLake Immunotherapeutics For: 29 July- Investing.com
Form 4 MoonLake Immunotherapeutics For: 21 July- Investing.com
- Form 4 MoonLake Immunotherapeutics For: 30 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
11 Buy
2 Hold
2 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 28.54
(+133.92% Upside)
MoonLake Immunotherapeutics SWOT Analysis
Pipeline Progress | Explore MoonLake's clear product development timeline, offering transparency and potential catalysts for growth in the competitive biopharmaceutical landscape |
Financial Challenges | Delve into MoonLake's financial health, balancing strong cash positions against projected losses and the implications for future growth and investor confidence |
Market Dynamics | Learn how MoonLake navigates a competitive market, with analyst price targets ranging from $65 to $104 amidst anticipated rival product launches |
Industry Potential | Discover the positive outlook for the biopharmaceutical sector, presenting opportunities for MoonLake to capitalize on unmet medical needs and technological advancements |
Earnings
Latest Release
Aug 10, 2026
EPS / Forecast
-0.84 / -0.93
Revenue / Forecast
-- / --
Compare MLTX to Peers and Sector
Metrics to compare | MLTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMLTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −4.0x | −0.4x | |
PEG Ratio | 0.11 | 0.01 | 0.00 | |
Price/Book | 2.4x | 5.7x | 2.6x | |
Price / LTM Sales | - | 12.9x | 3.0x | |
Upside (Analyst Target) | 134.7% | 238.5% | 54.5% | |
Fair Value Upside | Unlock | −11.9% | 7.8% | Unlock |
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the MoonLake Immunotherapeutics (MLTX) Stock Price Today?
The MoonLake Immunotherapeutics stock price today is 12.20 USD.
What Stock Exchange Does MoonLake Immunotherapeutics Trade On?
MoonLake Immunotherapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for MoonLake Immunotherapeutics?
The stock symbol for MoonLake Immunotherapeutics is "MLTX."
What Is the MoonLake Immunotherapeutics Market Cap?
As of today, MoonLake Immunotherapeutics market cap is 1.03B USD.
What Is MoonLake Immunotherapeutics's Earnings Per Share (TTM)?
The MoonLake Immunotherapeutics EPS (TTM) is -3.81.
When Is the Next MoonLake Immunotherapeutics Earnings Date?
MoonLake Immunotherapeutics will release its next earnings report on Nov 17, 2026.
From a Technical Analysis Perspective, Is MLTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has MoonLake Immunotherapeutics Stock Split?
MoonLake Immunotherapeutics has split 0 times.
How Many Employees Does MoonLake Immunotherapeutics Have?
MoonLake Immunotherapeutics has 130 employees.
What is the current trading status of MoonLake Immunotherapeutics (MLTX)?
As of Sep 15, 2026, MoonLake Immunotherapeutics (MLTX) is trading at a price of 12.20 USD, with a previous close of 12.68 USD. The stock has fluctuated within a day range of 12.02 USD to 12.70 USD, while its 52-week range spans from 5.95 USD to 62.75 USD.
What Is MoonLake Immunotherapeutics (MLTX) Price Target According to Analysts?
The average 12-month price target for MoonLake Immunotherapeutics is 28.54 USD, with a high estimate of 50 USD and a low estimate of 6 USD. 11 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +133.92% Upside potential.
What Is the MLTX Premarket Price?
MLTX's last pre-market stock price is 12.76 USD. The pre-market share volume is 3,010.00, and the stock has decreased by 0.08, or 0.63%.
What Is the MLTX After Hours Price?
MLTX's last after hours stock price is 12.27 USD, the stock has decreased by 0.07, or 0.57%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.